Becton, Dickinson and Company (BD), commonly known as BD, is a multinational medical technology company that has been a prominent figure in the healthcare industry for over a century. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD is recognized as a leader in providing a wide range of medical devices, instruments, and reagents that contribute to the diagnosis, treatment, and management of various health conditions.
BD operates across three main segments: Medical, Life Sciences, and Interventional. The Medical segment encompasses products such as medical surgical systems, infusion therapy systems, and diagnostic systems, offering solutions that support healthcare professionals in providing safe and effective patient care.
In the Life Sciences segment, BD offers laboratory equipment, consumables, and research reagents for academic, pharmaceutical, and biotechnology research. This segment provides essential tools for scientists and researchers to conduct experiments, analyze data, and make scientific advancements.
BD's Interventional segment focuses on products that help improve patient outcomes through minimally invasive procedures. This includes solutions for vascular access, urology, and oncology, with a commitment to enhancing procedural efficiency and patient comfort.
One of BD's notable contributions is its commitment to addressing global health challenges. The company engages in initiatives to combat infectious diseases, improve medication management, and enhance healthcare delivery in underserved communities. BD's dedication to social responsibility and sustainability underscores its broader impact beyond its core business.
BD's innovations have led to advancements in healthcare delivery and patient safety. For instance, the company is known for its contributions to the development of safety-engineered needles and syringes, which help reduce the risk of needlestick injuries for healthcare workers.